
Aethlon Medical AEMD
$ 4.37
-3.22%
Quarterly report 2025-Q2
added 08-13-2025
Aethlon Medical Book Value 2011-2025 | AEMD
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.12 M | 5.77 M | 15.1 M | 17 M | 9.29 M | 9.28 M | 2.3 M | 6.03 M | 595 K | 1.5 M | 651 K | -14.7 M | -9.14 M | -9.3 M | -5.98 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17 M | -14.7 M | 2.23 M |
Quarterly Book Value Aethlon Medical
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.42 M | 5.12 M | 4.33 M | 6.02 M | 8.71 M | 5.77 M | 7.61 M | 10.3 M | 13.1 M | 15.1 M | 17.3 M | 19.9 M | 14.9 M | 17 M | 20.6 M | 22.5 M | 25.9 M | 9.29 M | 11.4 M | 11.2 M | 13.8 M | 15.3 M | 3.8 M | 3.42 M | -633 K | 1.11 M | 3.17 M | 3.69 M | 3.93 M | 6.03 M | 4.6 M | 19.5 K | -950 K | 595 K | 1.08 K | -133 K | 375 K | 1.5 M | 2.71 M | 3.88 M | 5.08 M | 651 K | 1.29 M | -3.29 M | -3.52 M | -14.7 M | 2.11 M | 411 K | 195 K | -9.14 M | 307 K | 475 K | 823 K | 839 K | 903 K | 323 K | 322 K | 567 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25.9 M | -14.7 M | 5.16 M |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Dynatronics Corporation
DYNT
|
3.26 M | $ 0.24 | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
-38.6 M | $ 1.48 | 1.37 % | $ 20.5 M | ||
|
Natus Medical Incorporated
NTUS
|
425 M | $ 31.08 | 1.94 % | $ 1.05 B | ||
|
Lianluo Smart Limited
LLIT
|
272 M | $ 9.22 | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | $ 3.05 | -5.86 % | $ 30.6 M | ||
|
Cardiovascular Systems
CSII
|
249 M | $ 20.0 | 0.15 % | $ 844 M | ||
|
Neovasc
NVCN
|
52.2 M | $ 30.03 | - | $ 111 M | ||
|
Apollo Endosurgery
APEN
|
32.6 M | $ 10.0 | - | $ 475 M | ||
|
Titan Medical
TMDI
|
35.3 M | $ 0.14 | -26.32 % | $ 19.6 M | ||
|
Viveve Medical
VIVE
|
15.1 M | $ 0.22 | -15.35 % | $ 1.71 M | ||
|
Invacare Corporation
IVC
|
771 M | $ 0.66 | - | $ 24.7 M | ||
|
Abiomed
ABMD
|
1.33 B | $ 381.02 | - | $ 17.2 B | ||
|
Allied Healthcare Products
AHPI
|
19.7 M | $ 0.55 | 3.58 % | $ 2.21 M | ||
|
CHF Solutions, Inc.
CHFS
|
6.23 M | $ 5.28 | 1.15 % | $ 34.5 M | ||
|
CryoLife, Inc.
CRY
|
58.1 M | $ 17.84 | -4.14 % | $ 702 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
196 M | $ 24.04 | - | $ 1.77 B | ||
|
Soliton, Inc.
SOLY
|
243 M | $ 20.12 | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | $ 10.38 | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
229 M | $ 30.65 | 0.03 % | $ 1.58 B | ||
|
FONAR Corporation
FONR
|
146 M | $ 14.9 | 1.02 % | $ 97.7 M | ||
|
Misonix, Inc.
MSON
|
30.4 M | $ 26.54 | - | $ 462 M | ||
|
ShockWave Medical
SWAV
|
669 M | $ 334.75 | - | $ 12.3 B | ||
|
SeaSpine Holdings Corporation
SPNE
|
312 M | $ 7.16 | 0.28 % | $ 270 M | ||
|
ViewRay
VRAY
|
82.2 M | $ 2.64 | 1.54 % | $ 468 M | ||
|
Intersect ENT, Inc.
XENT
|
550 M | $ 28.24 | - | $ 955 M | ||
|
Bruker Corporation
BRKR
|
1.82 B | $ 39.01 | -2.96 % | $ 5.81 K | ||
|
Axonics Modulation Technologies
AXNX
|
570 M | $ 70.98 | - | $ 3.31 B | ||
|
Integer Holdings Corporation
ITGR
|
1.62 B | $ 66.65 | -2.19 % | $ 2.24 B | ||
|
BIOLASE
BIOL
|
1.96 M | $ 0.13 | -13.19 % | $ 166 K | ||
|
Eargo
EAR
|
101 M | $ 2.57 | - | $ 10.2 M | ||
|
Delcath Systems
DCTH
|
68.7 M | $ 8.57 | -1.27 % | $ 244 M | ||
|
SmileDirectClub
SDC
|
-385 M | $ 0.08 | -53.45 % | $ 9.71 M | ||
|
Globus Medical
GMED
|
4.18 B | $ 61.13 | -0.62 % | $ 8.3 B | ||
|
ThermoGenesis Holdings
THMO
|
3.32 M | $ 0.31 | -25.84 % | $ 171 K | ||
|
Acutus Medical
AFIB
|
-879 K | $ 0.09 | -26.83 % | $ 2.62 M | ||
|
ClearPoint Neuro
CLPT
|
25.4 M | $ 18.43 | 8.54 % | $ 498 M | ||
|
Surgalign Holdings
SRGA
|
-15.7 M | $ 0.18 | -32.98 % | $ 1.68 M | ||
|
Conformis
CFMS
|
54.2 M | $ 2.27 | - | $ 16.4 M | ||
|
OrthoPediatrics Corp.
KIDS
|
355 M | $ 16.33 | -0.24 % | $ 377 M | ||
|
Sientra
SIEN
|
40.9 M | $ 0.18 | -16.59 % | $ 10.3 M | ||
|
NuVasive
NUVA
|
2.22 B | $ 39.75 | - | $ 2.07 B | ||
|
Cutera
CUTR
|
-172 M | $ 0.1 | -10.19 % | $ 1.99 M | ||
|
Nemaura Medical
NMRD
|
-11.8 M | $ 0.11 | -17.8 % | $ 2.74 M | ||
|
Medtronic PLC
MDT
|
48.3 B | $ 90.21 | -0.21 % | $ 116 B | ||
|
Vapotherm
VAPO
|
-55.3 M | $ 1.27 | 6.72 % | $ 34 M | ||
|
Pulmonx Corporation
LUNG
|
85.8 M | $ 1.76 | 3.24 % | $ 68.8 M | ||
|
Myomo
MYO
|
6.36 M | $ 0.85 | -2.04 % | $ 5.99 M | ||
|
Talis Biomedical Corporation
TLIS
|
69.1 M | $ 4.38 | 3.55 % | $ 7.96 M | ||
|
Alphatec Holdings
ATEC
|
776 M | $ 19.34 | -1.93 % | $ 2.76 B | ||
|
Inari Medical
NARI
|
417 M | $ 79.97 | - | $ 4.23 B |